chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Back pain, Fatigue
Clinical narrative: Stomach pain; back pain; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), ABDOMINAL PAIN UPPER (Stomach pain) and BACK PAIN (back pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     The patient's past medical history included Amputation (One of the lower limbs amputated.). Concomitant products included OMEPRAZOLE, MAGNESIUM OXIDE, DEXTROMETHORPHAN POLISTIREX (ROBITUSSIN 12 HOUR COUGH RELIEF), CALCIUM, ATORVASTATIN, MONTELUKAST SODIUM (SINGULAIR), PREGABALIN (LYRICA), ESCITALOPRAM OXALATE (LEXAPRO), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), POTASSIUM, VITAMIN D2, NADOLOL, TERBUTALINE and HYDROMORPHONE.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced FATIGUE (Fatigue). On 14-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain) and BACK PAIN (back pain). At the time of the report, FATIGUE (Fatigue), ABDOMINAL PAIN UPPER (Stomach pain) and BACK PAIN (back pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment information provided as, Promethazine. Concomitant medications also include, Tomalin, Proguard, Sulphate, Bath Lysine.   This case was linked to MOD-2021-079114 (E2B Linked Report).; Sender's Comments:  MOD-2021-079114:
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Decreased appetite, Headache
Clinical narrative: loss of appetite; headaches; stomach ache; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (loss of appetite), HEADACHE (headaches) and ABDOMINAL PAIN UPPER (stomach ache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 032B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced DECREASED APPETITE (loss of appetite), HEADACHE (headaches) and ABDOMINAL PAIN UPPER (stomach ache). On 13-Apr-2021, DECREASED APPETITE (loss of appetite), HEADACHE (headaches) and ABDOMINAL PAIN UPPER (stomach ache) had resolved.          Patient has used ibuprofen, Pepto Bismol,, BRAT diet, and turmeric tea.   Reporter did not allow further contact
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site induration
Clinical narrative: Injection site felt hard; Injection site felt bruised; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Injection site felt hard) and VACCINATION SITE BRUISING (Injection site felt bruised) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced VACCINATION SITE INDURATION (Injection site felt hard) and VACCINATION SITE BRUISING (Injection site felt bruised). At the time of the report, VACCINATION SITE INDURATION (Injection site felt hard) and VACCINATION SITE BRUISING (Injection site felt bruised) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were provided.  No treatment medication were provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 01-Aug-2021: Follow up received and contained non-significant information: reported denied to make further follow up.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: muscle spams; itching around the injection site; I had some swelling around the injection site; redness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (muscle spams), VACCINATION SITE PRURITUS (itching around the injection site), VACCINATION SITE SWELLING (I had some swelling around the injection site) and VACCINATION SITE ERYTHEMA (redness around the injection site) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (itching around the injection site), VACCINATION SITE SWELLING (I had some swelling around the injection site) and VACCINATION SITE ERYTHEMA (redness around the injection site). On 15-Apr-2021, the patient experienced MUSCLE SPASMS (muscle spams). On 05-Apr-2021, VACCINATION SITE PRURITUS (itching around the injection site) and VACCINATION SITE SWELLING (I had some swelling around the injection site) outcome was unknown. At the time of the report, MUSCLE SPASMS (muscle spams) and VACCINATION SITE ERYTHEMA (redness around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       LOT: 019 "B" 211A (not sure if the "B" is a B or 13), No treatment information were provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Excessive granulation tissue, Fatigue, Injection site pain, Injection site rash
Clinical narrative: Fatigue; scar tissue; rash at the injection site with itchy; arm  hurt; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), INJECTION SITE PAIN (arm  hurt), INJECTION SITE RASH (rash at the injection site with itchy) and EXCESSIVE GRANULATION TISSUE (scar tissue) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and RALOXIFENE HYDROCHLORIDE (EVISTA) for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced INJECTION SITE PAIN (arm  hurt). On 12-Mar-2021, the patient experienced INJECTION SITE RASH (rash at the injection site with itchy) and EXCESSIVE GRANULATION TISSUE (scar tissue). On an unknown date, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue), INJECTION SITE PAIN (arm  hurt) and EXCESSIVE GRANULATION TISSUE (scar tissue) had resolved and INJECTION SITE RASH (rash at the injection site with itchy) outcome was unknown. Not Provided          patient received the treatment includes: hydrocortisone   This case was linked to MOD-2021-045102 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: NNI: AE contact information was updated
Sex: F
Vaccine: COVID19
Symptoms: Cough, Lymphadenopathy, Sinus headache, Sneezing
Clinical narrative: coughing; sinus pressure headache; swollen lymph nodes; sneezing; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (coughing), SINUS HEADACHE (sinus pressure headache), LYMPHADENOPATHY (swollen lymph nodes) and SNEEZING (sneezing) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse effect.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced COUGH (coughing), SINUS HEADACHE (sinus pressure headache), LYMPHADENOPATHY (swollen lymph nodes) and SNEEZING (sneezing). At the time of the report, COUGH (coughing), SINUS HEADACHE (sinus pressure headache), LYMPHADENOPATHY (swollen lymph nodes) and SNEEZING (sneezing) outcome was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse effect.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in the arm). At the time of the report, PAIN IN EXTREMITY (pain in the arm) outcome was unknown. Not Provided
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pain in extremity
Clinical narrative: real bad headache; arm sore; really really tired; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (real bad headache), PAIN IN EXTREMITY (arm sore), FATIGUE (really really tired) and NAUSEA (nauseous) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006821A) for COVID-19 vaccination.     The patient's past medical history included No adverse effect.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 12-Apr-2021, the patient experienced HEADACHE (real bad headache), PAIN IN EXTREMITY (arm sore), FATIGUE (really really tired) and NAUSEA (nauseous). At the time of the report, HEADACHE (real bad headache), PAIN IN EXTREMITY (arm sore), FATIGUE (really really tired) and NAUSEA (nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Culture urine, Exposure during pregnancy, Pregnancy test, Ultrasound scan
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 028A21A) for COVID-19 vaccination.     The patient's past medical history included Endometriosis. Concurrent medical conditions included Drug allergy (Sulfa drugs). Concomitant products included VITAMIN D3.   On 04-Mar-2021 at 10:40 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021 at 9:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 11-Nov-2020 and the estimated date of delivery was 18-Aug-2021. On 04-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  sixteenth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Dec-2020, Pregnancy test: positive Positive. On 13-Jan-2021, Ultrasound scan: normal Normal. On 31-Mar-2021, Culture urine: positive Positive for UTI. On 31-Mar-2021, Ultrasound scan: normal Normal.         No Treatment related information was reported. The 11-Nov-2020, was considered to be an estimated date of conception. Patient had 0 previous pregnancies. The patient was taking Pre-Natal Multi Plus DHA 100 ml as supplement.
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Facial pain, Hyperaesthesia, Nasal congestion, Sinusitis
Clinical narrative: sinusitis; very congested; face, nose, eyes and head hurt a lot; swelling on her forehead and on the head and neck; ears are plugged and unplugged; Could not bear to have her pillow touch her head/back of neck; This spontaneous case was reported by a physician and describes the occurrence of SINUSITIS (sinusitis), NASAL CONGESTION (very congested), FACIAL PAIN (face, nose, eyes and head hurt a lot), SWELLING (swelling on her forehead and on the head and neck) and EAR DISCOMFORT (ears are plugged and unplugged) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included METFORMIN and OMEPRAZOLE for an unknown indication.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced SINUSITIS (sinusitis), NASAL CONGESTION (very congested), FACIAL PAIN (face, nose, eyes and head hurt a lot), SWELLING (swelling on her forehead and on the head and neck), EAR DISCOMFORT (ears are plugged and unplugged) and HYPERAESTHESIA (Could not bear to have her pillow touch her head/back of neck). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SINUSITIS (sinusitis), NASAL CONGESTION (very congested), FACIAL PAIN (face, nose, eyes and head hurt a lot), SWELLING (swelling on her forehead and on the head and neck), EAR DISCOMFORT (ears are plugged and unplugged) and HYPERAESTHESIA (Could not bear to have her pillow touch her head/back of neck) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 in response to the event was not applicable. Treatment: Antibiotics, nasal spray and Tylenol for the symptoms.   This case was linked to MOD-2021-036905 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: the follow-up were received on 24-MAY-2021 and contain no new information On 24-May-2021: Translated email added
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: sinusitis; very congested; face, nose, eyes and head hurt a lot; swelling on her forehead and on the head and neck; ears are plugged and unplugged; Could not bear to have her pillow touch her head/back of neck; This spontaneous case was reported by a physician and describes the occurrence of SINUSITIS (sinusitis), NASAL CONGESTION (very congested), FACIAL PAIN (face, nose, eyes and head hurt a lot), SWELLING (swelling on her forehead and on the head and neck) and EAR DISCOMFORT (ears are plugged and unplugged) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included METFORMIN and OMEPRAZOLE for an unknown indication.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced SINUSITIS (sinusitis), NASAL CONGESTION (very congested), FACIAL PAIN (face, nose, eyes and head hurt a lot), SWELLING (swelling on her forehead and on the head and neck), EAR DISCOMFORT (ears are plugged and unplugged) and HYPERAESTHESIA (Could not bear to have her pillow touch her head/back of neck). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SINUSITIS (sinusitis), NASAL CONGESTION (very congested), FACIAL PAIN (face, nose, eyes and head hurt a lot), SWELLING (swelling on her forehead and on the head and neck), EAR DISCOMFORT (ears are plugged and unplugged) and HYPERAESTHESIA (Could not bear to have her pillow touch her head/back of neck) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 in response to the event was not applicable. Treatment: Antibiotics, nasal spray and Tylenol for the symptoms.   This case was linked to MOD-2021-036905 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: the follow-up were received on 24-MAY-2021 and contain no new information On 24-May-2021: Translated email added
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Skin swelling, Swelling, Tonsillar hypertrophy
Clinical narrative: Swollen tonsils; Swollen armpits and groin; Feeling puffiness, without anaphylaxis; Swollen lymph node; This spontaneous case was reported by a consumer and describes the occurrence of TONSILLAR HYPERTROPHY (Swollen tonsils), SWELLING (Swollen armpits and groin), SKIN SWELLING (Feeling puffiness, without anaphylaxis) and LYMPHADENOPATHY (Swollen lymph node) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     Concomitant products included ALPRAZOLAM for Anxiety, TESTOSTERONE for Hormone therapy, MECLIZINE HCL for Vertigo, MULTIVITAMIN [VITAMINS NOS] for Vitamin supplementation.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced TONSILLAR HYPERTROPHY (Swollen tonsils), SWELLING (Swollen armpits and groin), SKIN SWELLING (Feeling puffiness, without anaphylaxis) and LYMPHADENOPATHY (Swollen lymph node). At the time of the report, TONSILLAR HYPERTROPHY (Swollen tonsils), SWELLING (Swollen armpits and groin), SKIN SWELLING (Feeling puffiness, without anaphylaxis) and LYMPHADENOPATHY (Swollen lymph node) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not provided.   This case was linked to MOD21-066409 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Follow up received: No significant information was received.; Sender's Comments:  MOD21-066409:
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Nausea, Pain, Pain in extremity
Clinical narrative: Flu-like symptoms; Sore arm; Body aches; Little nausea; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN IN EXTREMITY (Sore arm), PAIN (Body aches) and NAUSEA (Little nausea) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN IN EXTREMITY (Sore arm), PAIN (Body aches) and NAUSEA (Little nausea). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN IN EXTREMITY (Sore arm), PAIN (Body aches) and NAUSEA (Little nausea) was resolving. Not Provided          Concomitant product use was not provided. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was  not applicable.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Feeling cold, Pain, Pyrexia
Clinical narrative: Feeling cold; Ache all over; Fever of 102 degrees; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Feeling cold), PAIN (Ache all over) and PYREXIA (Fever of 102 degrees) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced FEELING COLD (Feeling cold), PAIN (Ache all over) and PYREXIA (Fever of 102 degrees). At the time of the report, FEELING COLD (Feeling cold), PAIN (Ache all over) and PYREXIA (Fever of 102 degrees) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Apr-2021, Body temperature: 102 (High) fever of 102 degrees.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment medication was not provided.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Peripheral swelling, Red blood cell count, Red blood cell count decreased
Clinical narrative: white blood count was high; red blood count was low; shaking; hands were swollen; pain in joints; Headache; This spontaneous case was reported by a consumer and describes the occurrence of WHITE BLOOD CELL COUNT INCREASED (white blood count was high), RED BLOOD CELL COUNT DECREASED (red blood count was low), TREMOR (shaking), PERIPHERAL SWELLING (hands were swollen) and ARTHRALGIA (pain in joints) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Osteoarthritis. Concomitant products included CELECOXIB, OMEPRAZOLE, PRAVASTATIN, METOPROLOL SUCCINATE, VENLAFAXINE and LISINOPRIL for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced HEADACHE (Headache). On 28-Mar-2021, the patient experienced WHITE BLOOD CELL COUNT INCREASED (white blood count was high), RED BLOOD CELL COUNT DECREASED (red blood count was low), TREMOR (shaking), PERIPHERAL SWELLING (hands were swollen) and ARTHRALGIA (pain in joints). The patient was treated with MORPHINE for Inflammation, at an unspecified dose and frequency; PREDNISONE for Inflammation, at an unspecified dose and frequency and ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, WHITE BLOOD CELL COUNT INCREASED (white blood count was high), RED BLOOD CELL COUNT DECREASED (red blood count was low), TREMOR (shaking), PERIPHERAL SWELLING (hands were swollen), ARTHRALGIA (pain in joints) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Mar-2021, Red blood cell count: low (Low) Low. On 28-Mar-2021, White blood cell count: high (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient went to the emergency room on 29-MAR-2021 and was released in a few hours.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor, White blood cell count, White blood cell count increased
Clinical narrative: white blood count was high; red blood count was low; shaking; hands were swollen; pain in joints; Headache; This spontaneous case was reported by a consumer and describes the occurrence of WHITE BLOOD CELL COUNT INCREASED (white blood count was high), RED BLOOD CELL COUNT DECREASED (red blood count was low), TREMOR (shaking), PERIPHERAL SWELLING (hands were swollen) and ARTHRALGIA (pain in joints) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Osteoarthritis. Concomitant products included CELECOXIB, OMEPRAZOLE, PRAVASTATIN, METOPROLOL SUCCINATE, VENLAFAXINE and LISINOPRIL for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced HEADACHE (Headache). On 28-Mar-2021, the patient experienced WHITE BLOOD CELL COUNT INCREASED (white blood count was high), RED BLOOD CELL COUNT DECREASED (red blood count was low), TREMOR (shaking), PERIPHERAL SWELLING (hands were swollen) and ARTHRALGIA (pain in joints). The patient was treated with MORPHINE for Inflammation, at an unspecified dose and frequency; PREDNISONE for Inflammation, at an unspecified dose and frequency and ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, WHITE BLOOD CELL COUNT INCREASED (white blood count was high), RED BLOOD CELL COUNT DECREASED (red blood count was low), TREMOR (shaking), PERIPHERAL SWELLING (hands were swollen), ARTHRALGIA (pain in joints) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Mar-2021, Red blood cell count: low (Low) Low. On 28-Mar-2021, White blood cell count: high (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient went to the emergency room on 29-MAR-2021 and was released in a few hours.
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Chills, Headache, Nausea, Pyrexia
Clinical narrative: nauseas; fever 102°F; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nauseas), PYREXIA (fever 102°F), CHILLS (Chills) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NAUSEA (nauseas), PYREXIA (fever 102°F), CHILLS (Chills) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, NAUSEA (nauseas), PYREXIA (fever 102°F), CHILLS (Chills) and HEADACHE (Headache) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: low (Low) Lowered. On an unknown date, Pyrexia: 102 (Inconclusive) 102 F.         No concomitant medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.   The caller was a patient who was warm transferred from costumer care under case number MOD21-00147687. The patient received both doses of the Moderna COVID-19 Vaccine and reported side effects after the second dose. The patient has hypertension and started monitoring the blood pressure after the vaccination and it's been lowered. The patient wanted to know if Is it related with being vaccinated?
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Administration site bruise, Injection site pain, Insomnia, Myalgia, Pain
Clinical narrative: Pain was worse on the left side; Went from her shoulder to her joint to her back and up to her neck; Tenderness under the arm which may be related to the lymph nodes.; Pain occurs at random times and it makes it difficult for her to sleep; Vaccination site is still bruised; Muscle pain primarily in the arm; Felt pain in her arm from the injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain was worse on the left side), PAIN IN EXTREMITY (Went from her shoulder to her joint to her back and up to her neck), TENDERNESS (Tenderness under the arm which may be related to the lymph nodes.), INSOMNIA (Pain occurs at random times and it makes it difficult for her to sleep) and ADMINISTRATION SITE BRUISE (Vaccination site is still bruised) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced INJECTION SITE PAIN (Felt pain in her arm from the injection). On an unknown date, the patient experienced PAIN (Pain was worse on the left side), PAIN IN EXTREMITY (Went from her shoulder to her joint to her back and up to her neck), TENDERNESS (Tenderness under the arm which may be related to the lymph nodes.), INSOMNIA (Pain occurs at random times and it makes it difficult for her to sleep), ADMINISTRATION SITE BRUISE (Vaccination site is still bruised) and MYALGIA (Muscle pain primarily in the arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and EUGENOL, MENTHOL, METHYL SALICYLATE (HEAT) at an unspecified dose and frequency. At the time of the report, PAIN (Pain was worse on the left side), PAIN IN EXTREMITY (Went from her shoulder to her joint to her back and up to her neck), TENDERNESS (Tenderness under the arm which may be related to the lymph nodes.), INSOMNIA (Pain occurs at random times and it makes it difficult for her to sleep), ADMINISTRATION SITE BRUISE (Vaccination site is still bruised), INJECTION SITE PAIN (Felt pain in her arm from the injection) and MYALGIA (Muscle pain primarily in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  The patient experienced pain which has been there for the last 2.5 weeks.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Tenderness
Clinical narrative: Pain was worse on the left side; Went from her shoulder to her joint to her back and up to her neck; Tenderness under the arm which may be related to the lymph nodes.; Pain occurs at random times and it makes it difficult for her to sleep; Vaccination site is still bruised; Muscle pain primarily in the arm; Felt pain in her arm from the injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain was worse on the left side), PAIN IN EXTREMITY (Went from her shoulder to her joint to her back and up to her neck), TENDERNESS (Tenderness under the arm which may be related to the lymph nodes.), INSOMNIA (Pain occurs at random times and it makes it difficult for her to sleep) and ADMINISTRATION SITE BRUISE (Vaccination site is still bruised) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced INJECTION SITE PAIN (Felt pain in her arm from the injection). On an unknown date, the patient experienced PAIN (Pain was worse on the left side), PAIN IN EXTREMITY (Went from her shoulder to her joint to her back and up to her neck), TENDERNESS (Tenderness under the arm which may be related to the lymph nodes.), INSOMNIA (Pain occurs at random times and it makes it difficult for her to sleep), ADMINISTRATION SITE BRUISE (Vaccination site is still bruised) and MYALGIA (Muscle pain primarily in the arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and EUGENOL, MENTHOL, METHYL SALICYLATE (HEAT) at an unspecified dose and frequency. At the time of the report, PAIN (Pain was worse on the left side), PAIN IN EXTREMITY (Went from her shoulder to her joint to her back and up to her neck), TENDERNESS (Tenderness under the arm which may be related to the lymph nodes.), INSOMNIA (Pain occurs at random times and it makes it difficult for her to sleep), ADMINISTRATION SITE BRUISE (Vaccination site is still bruised), INJECTION SITE PAIN (Felt pain in her arm from the injection) and MYALGIA (Muscle pain primarily in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  The patient experienced pain which has been there for the last 2.5 weeks.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Musculoskeletal stiffness, Myalgia
Clinical narrative: stiffness; feeling foggy; tiredness; body aches; headache; Chills; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiffness), FEELING ABNORMAL (feeling foggy), SOMNOLENCE (tiredness), PAIN (body aches) and HEADACHE (headache) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CELECOXIB (CELEXA [CELECOXIB]), ERGOCALCIFEROL (DRISDOL), GABAPENTIN, QUETIAPINE FUMARATE (SEROQUEL) and AMLODIPINE for an unknown indication.    On 11-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (stiffness), FEELING ABNORMAL (feeling foggy), SOMNOLENCE (tiredness), PAIN (body aches), HEADACHE (headache), CHILLS (Chills) and MYALGIA (muscle aches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL STIFFNESS (stiffness), FEELING ABNORMAL (feeling foggy), SOMNOLENCE (tiredness), PAIN (body aches), HEADACHE (headache), CHILLS (Chills) and MYALGIA (muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Somnolence
Clinical narrative: stiffness; feeling foggy; tiredness; body aches; headache; Chills; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiffness), FEELING ABNORMAL (feeling foggy), SOMNOLENCE (tiredness), PAIN (body aches) and HEADACHE (headache) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CELECOXIB (CELEXA [CELECOXIB]), ERGOCALCIFEROL (DRISDOL), GABAPENTIN, QUETIAPINE FUMARATE (SEROQUEL) and AMLODIPINE for an unknown indication.    On 11-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (stiffness), FEELING ABNORMAL (feeling foggy), SOMNOLENCE (tiredness), PAIN (body aches), HEADACHE (headache), CHILLS (Chills) and MYALGIA (muscle aches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL STIFFNESS (stiffness), FEELING ABNORMAL (feeling foggy), SOMNOLENCE (tiredness), PAIN (body aches), HEADACHE (headache), CHILLS (Chills) and MYALGIA (muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Nodule, Vaccination site erythema, Vaccination site pain, Vaccination site reaction, Vision blurred
Clinical narrative: red knot; screen was blurry; covid arm; big red 2 inch circle on arm; really really sore; This spontaneous case was reported by a consumer and describes the occurrence of NODULE (red knot), VISION BLURRED (screen was blurry), VACCINATION SITE REACTION (covid arm), VACCINATION SITE ERYTHEMA (big red 2 inch circle on arm) and VACCINATION SITE PAIN (really really sore) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 013A21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: FLU VACCINE VII (Flu shot was taken in left arm and is still sore.). Concomitant products included GABAPENTIN for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NODULE (red knot), VISION BLURRED (screen was blurry), VACCINATION SITE REACTION (covid arm), VACCINATION SITE ERYTHEMA (big red 2 inch circle on arm) and VACCINATION SITE PAIN (really really sore). At the time of the report, NODULE (red knot), VACCINATION SITE ERYTHEMA (big red 2 inch circle on arm) and VACCINATION SITE PAIN (really really sore) had not resolved and VISION BLURRED (screen was blurry) and VACCINATION SITE REACTION (covid arm) outcome was unknown.            No treatment medications were provided.  Action taken in response to mRNA-1273 is considered to be not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: FU received, Possibly NNI
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Rash
Clinical narrative: Swollen Both Legs; Rash on both legs; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen Both Legs) and RASH (Rash on both legs) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced PERIPHERAL SWELLING (Swollen Both Legs) and RASH (Rash on both legs). At the time of the report, PERIPHERAL SWELLING (Swollen Both Legs) and RASH (Rash on both legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment medications were provided.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: Fever of 101.3 F; Feeling tired, went to sleep again; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 101.3 F) and FATIGUE (Feeling tired, went to sleep again) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced PYREXIA (Fever of 101.3 F) and FATIGUE (Feeling tired, went to sleep again). At the time of the report, PYREXIA (Fever of 101.3 F) and FATIGUE (Feeling tired, went to sleep again) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 100.3 (High) 100.3F.            No concomitant medications were reported. No treatment medication were reported. Action taken with m-RNA 1273 was not applicable.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Gastritis
Clinical narrative: Stomach pain one month; stomach is severe inflame; Severe stomach pain; This spontaneous case was reported by a consumer and describes the occurrence of GASTRITIS (stomach is severe inflame), ABDOMINAL PAIN UPPER (Severe stomach pain) and ABDOMINAL PAIN UPPER (Stomach pain one month) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041b21a) for COVID-19 vaccination.     Concurrent medical conditions included Heartburn, GERD since August 2011 and Iodine allergy. Concomitant products included RABEPRAZOLE SODIUM (ACIPHEX), MAGNESIUM and CALCIUM for an unknown indication.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, the patient experienced GASTRITIS (stomach is severe inflame). 10-May-2021, the patient experienced ABDOMINAL PAIN UPPER (Severe stomach pain). On 10-Jun-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain one month). At the time of the report, GASTRITIS (stomach is severe inflame) and ABDOMINAL PAIN UPPER (Severe stomach pain) had resolved and ABDOMINAL PAIN UPPER (Stomach pain one month) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported. the patient race was reported as Middle Eastern.   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Follow up information was received wherein events, medical history and batch number was added. On 09-Aug-2021: Follow up  received which contains no new information.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dizziness, Eye pain, Fatigue
Clinical narrative: fever; lymph node swelling under arm; chills; fatigue; off and on headaches; muscle aches / Body ache/ arm soreness; diarrhea; runny nose; dizziness; increased heartbeat; brain fog; eyeballs hurt; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), LYMPHADENOPATHY (lymph node swelling under arm), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (off and on headaches) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 003B21A) for COVID-19 vaccination.   The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer, Lymphedema, , Mastectomy bilateral, Gallbladder removal and Hysterectomy.  Concurrent medical conditions included Drug allergy (Multiple drug allergies but not listed.).   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.   On 08-Mar-2021, the patient experienced PYREXIA (fever), LYMPHADENOPATHY (lymph node swelling under arm), CHILLS (chills), FATIGUE (fatigue), HEADACHE (off and on headaches), MYALGIA (muscle aches / Body ache/ arm soreness), DIARRHOEA (diarrhea), RHINORRHOEA (runny nose), DIZZINESS (dizziness), HEART RATE INCREASED (increased heartbeat), FEELING ABNORMAL (brain fog) and EYE PAIN (eyeballs hurt).   On 12-Mar-2021, PYREXIA (fever), LYMPHADENOPATHY (lymph node swelling under arm), CHILLS (chills), FATIGUE (fatigue), HEADACHE (off and on headaches), MYALGIA (muscle aches / Body ache/ arm soreness), DIARRHOEA (diarrhea), RHINORRHOEA (runny nose), DIZZINESS (dizziness), HEART RATE INCREASED (increased heartbeat), FEELING ABNORMAL (brain fog) and EYE PAIN (eyeballs hurt) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   This case was linked to US-MODERNATX, INC.-MOD-2021-079460 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-079460:SECOND  Dose Events
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Heart rate increased, Lymphadenopathy, Myalgia
Clinical narrative: fever; lymph node swelling under arm; chills; fatigue; off and on headaches; muscle aches / Body ache/ arm soreness; diarrhea; runny nose; dizziness; increased heartbeat; brain fog; eyeballs hurt; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), LYMPHADENOPATHY (lymph node swelling under arm), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (off and on headaches) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 003B21A) for COVID-19 vaccination.   The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer, Lymphedema, , Mastectomy bilateral, Gallbladder removal and Hysterectomy.  Concurrent medical conditions included Drug allergy (Multiple drug allergies but not listed.).   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.   On 08-Mar-2021, the patient experienced PYREXIA (fever), LYMPHADENOPATHY (lymph node swelling under arm), CHILLS (chills), FATIGUE (fatigue), HEADACHE (off and on headaches), MYALGIA (muscle aches / Body ache/ arm soreness), DIARRHOEA (diarrhea), RHINORRHOEA (runny nose), DIZZINESS (dizziness), HEART RATE INCREASED (increased heartbeat), FEELING ABNORMAL (brain fog) and EYE PAIN (eyeballs hurt).   On 12-Mar-2021, PYREXIA (fever), LYMPHADENOPATHY (lymph node swelling under arm), CHILLS (chills), FATIGUE (fatigue), HEADACHE (off and on headaches), MYALGIA (muscle aches / Body ache/ arm soreness), DIARRHOEA (diarrhea), RHINORRHOEA (runny nose), DIZZINESS (dizziness), HEART RATE INCREASED (increased heartbeat), FEELING ABNORMAL (brain fog) and EYE PAIN (eyeballs hurt) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   This case was linked to US-MODERNATX, INC.-MOD-2021-079460 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-079460:SECOND  Dose Events